Abbott Agrees $1.6bn Depakote Settlement
Tuesday, May 8, 2012 9:45The US drug company–Abbott Labs agreed to a $1.6bn settlement with the US Department of Justice over illegal marketing of the drug–Depakote, which is used to treat bipolar disorder. The settlement marks the end of a four-year investigation into Abbott’s selling of Depakote and represents one of the largest consumer protection settlements that involves a drug company.
According to the justice department, it is said that penalties are the second largest ever for a drug company, eclipsed only by $2.3bn fine imposed on Pfizer in the year of 2009 for promoting uses of four of its drugs illegally.








